The treatment of osteoporosis. Antiresorptive therapy

Clin Lab Med. 2000 Sep;20(3):603-22, viii.

Abstract

Antiresorptive pharmacologic interventions for the prevention and treatment of osteoporosis are discussed. These interventions include estrogen; calcitonin; biphosphonates; and selective estrogen receptor modulators and their use in postmenopausal osteoporosis, steroid-induced osteoporosis, and osteoporosis in men. The effects of antiresorptive therapy on bone mineral density, biomarkers of bone turnover, and fracture risk are discussed.

Publication types

  • Review

MeSH terms

  • Bone Density
  • Bone Remodeling
  • Bone Resorption / prevention & control*
  • Bone and Bones / injuries
  • Calcitonin / therapeutic use
  • Calcium / therapeutic use
  • Diphosphonates / therapeutic use
  • Estrogens / therapeutic use
  • Female
  • Fractures, Bone / prevention & control
  • Humans
  • Male
  • Osteoporosis / drug therapy*
  • Osteoporosis, Postmenopausal / drug therapy
  • Osteoporosis, Postmenopausal / prevention & control
  • Randomized Controlled Trials as Topic
  • Vitamin D / therapeutic use

Substances

  • Diphosphonates
  • Estrogens
  • Vitamin D
  • Calcitonin
  • Calcium